Carolina Ferrairo Danieletto1, Gustavo Zanna Ferreira2, Gustavo Jacobucci Farah3, Roberto Kenji Nakamura Cuman4. 1. Master Student, Implantodonty, Araçatuba Dentistry School, UNESP - Universidade Estadual Paulista, Araçatuba, São Paulo, Brazil. 2. Professor, Dental Surgery, Department of Dentistry, UNICESUMAR - Cesumar University Center, Maringá, Paraná, Brazil. 3. Associated Professor, Dental Surgery, State University of Maringá, Paraná, Brazil. 4. Associated Professor, Pharmacology, State University of Maringá, Paraná, Brazil.
Abstract
INTRODUCTION: Thrombocytopenia is the reduction in the number of blood -platelets, which may be caused by -several different conditions such as sepsis, disseminated intravascular -clotting, and large blood losses. Additionally, in rare situations, thrombocytopenia may also be induced by the use of medicaments. One of these drugs is the vancomycin, a glycopeptide presently used against -serious infections involving Gram-positive bacteria such as the methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus. OBJECTIVE: The objective of this study is to report on a case of serious vancomycin-induced thrombocytopenia in a patient infected with methicillin-resistant S. aureus after mandibular reconstruction with autogenous bone graft, and to draw attention to the importance of this clinically rare adverse effect. CONCLUSION: Vancomycin-induced thrombocytopenia is a rare condition, which is also a significant disorder that demands attention and the rapid identification and replacement of the antimicrobial agent.
INTRODUCTION:Thrombocytopenia is the reduction in the number of blood -platelets, which may be caused by -several different conditions such as sepsis, disseminated intravascular -clotting, and large blood losses. Additionally, in rare situations, thrombocytopenia may also be induced by the use of medicaments. One of these drugs is the vancomycin, a glycopeptide presently used against -serious infections involving Gram-positive bacteria such as the methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus. OBJECTIVE: The objective of this study is to report on a case of serious vancomycin-induced thrombocytopenia in a patient infected with methicillin-resistant S. aureus after mandibular reconstruction with autogenous bone graft, and to draw attention to the importance of this clinically rare adverse effect. CONCLUSION:Vancomycin-induced thrombocytopenia is a rare condition, which is also a significant disorder that demands attention and the rapid identification and replacement of the antimicrobial agent.